GlassScriptPhysician profile
Ellen Holm
NPI 1942606413
$3,353.90
in general payments reported to CMS, 2019-2025
22 companies · $723 in 2025
The $723 reported for 2025 was more than what 80% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $516 · 2022: $624 · 2023: $578 · 2024: $912 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $791.44 | 2021-2023 | Cardiomems, Xience Sierra |
| Astrazeneca Pharmaceuticals LP | $473.95 | 2023-2025 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $260.51 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.82 | 2021-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.91 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $183.27 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $180.23 | 2023-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $124.16 | 2024-2025 | |
| Ardelyx, INC. | $118.72 | 2024-2025 | Ibsrela |
| Amgen INC. | $101.79 | 2024-2025 | Krystexxa, Tavneos |
| Calliditas Therapeutics US INC. | $98.61 | 2025 | Tarpeyo |
| Travere Therapeutics, INC. | $95.16 | 2025 | |
| Abbvie INC. | $90.60 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $67.86 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $67.29 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $61.05 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.44 | 2024-2025 | Gattex |
| Genzyme Corporation | $41.86 | 2023 | |
| Janssen Pharmaceuticals, INC | $36.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $22.98 | 2025 | Jynarque |
| Teleflex LLC | $18.51 | 2022 | |
| Scpharmaceuticals INC. | $14.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Holm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.